The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The FDA and CDC recommended the pause while the government looks into possible side effects. Also: RFK Jr. raises eyebrows after swimming with his grandkids in a contaminated creek; President Donald ...

Federal health officials are advising Americans aged 60 and older to avoid the chikungunya vaccine Ixchiq amid an ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...